179 related articles for article (PubMed ID: 20922813)
1. Controlling ligand surface density optimizes nanoparticle binding to ICAM-1.
Fakhari A; Baoum A; Siahaan TJ; Le KB; Berkland C
J Pharm Sci; 2011 Mar; 100(3):1045-56. PubMed ID: 20922813
[TBL] [Abstract][Full Text] [Related]
2. PLGA nanoparticle--peptide conjugate effectively targets intercellular cell-adhesion molecule-1.
Zhang N; Chittasupho C; Duangrat C; Siahaan TJ; Berkland C
Bioconjug Chem; 2008 Jan; 19(1):145-52. PubMed ID: 17997512
[TBL] [Abstract][Full Text] [Related]
3. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells.
Chittasupho C; Xie SX; Baoum A; Yakovleva T; Siahaan TJ; Berkland CJ
Eur J Pharm Sci; 2009 May; 37(2):141-50. PubMed ID: 19429421
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells.
Punfa W; Yodkeeree S; Pitchakarn P; Ampasavate C; Limtrakul P
Acta Pharmacol Sin; 2012 Jun; 33(6):823-31. PubMed ID: 22580738
[TBL] [Abstract][Full Text] [Related]
5. Surface Layer Modification of Poly(d,l-lactic- co-glycolic acid) Nanoparticles with Targeting Peptide: A Convenient Synthetic Route for Pluronic F127-Tuftsin Conjugate.
Horváti K; Gyulai G; Csámpai A; Rohonczy J; Kiss É; Bősze S
Bioconjug Chem; 2018 May; 29(5):1495-1499. PubMed ID: 29669198
[TBL] [Abstract][Full Text] [Related]
6. Impact of surfactants on the target recognition of Fab-conjugated PLGA nanoparticles.
Kennedy PJ; Perreira I; Ferreira D; Nestor M; Oliveira C; Granja PL; Sarmento B
Eur J Pharm Biopharm; 2018 Jun; 127():366-370. PubMed ID: 29549023
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates.
Park J; Mattessich T; Jay SM; Agawu A; Saltzman WM; Fahmy TM
J Control Release; 2011 Nov; 156(1):109-15. PubMed ID: 21723893
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
[TBL] [Abstract][Full Text] [Related]
9. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
Srivastava S; Gupta S; Mohammad S; Ahmad I
J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
[TBL] [Abstract][Full Text] [Related]
10. Interfacial activity assisted surface functionalization: a novel approach to incorporate maleimide functional groups and cRGD peptide on polymeric nanoparticles for targeted drug delivery.
Toti US; Guru BR; Grill AE; Panyam J
Mol Pharm; 2010 Aug; 7(4):1108-17. PubMed ID: 20527782
[TBL] [Abstract][Full Text] [Related]
11. Engineering PLGA nano-based systems through understanding the influence of nanoparticle properties and cell-penetrating peptides for cochlear drug delivery.
Cai H; Liang Z; Huang W; Wen L; Chen G
Int J Pharm; 2017 Oct; 532(1):55-65. PubMed ID: 28870763
[TBL] [Abstract][Full Text] [Related]
12. Cell penetrating peptide-modified poly(lactic-co-glycolic acid) nanoparticles with enhanced cell internalization.
Steinbach JM; Seo YE; Saltzman WM
Acta Biomater; 2016 Jan; 30():49-61. PubMed ID: 26602822
[TBL] [Abstract][Full Text] [Related]
13. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP
Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749
[TBL] [Abstract][Full Text] [Related]
14. Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies.
Khan AM; Ahmad FJ; Panda AK; Talegaonkar S
Int J Pharm; 2016 Jun; 507(1-2):61-71. PubMed ID: 27154254
[TBL] [Abstract][Full Text] [Related]
15. Spermidine-mediated poly(lactic-
Tang J; Li J; Li G; Zhang H; Wang L; Li D; Ding J
Int J Nanomedicine; 2017; 12():6687-6704. PubMed ID: 28932114
[TBL] [Abstract][Full Text] [Related]
16. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery.
Vasconcelos A; Vega E; Pérez Y; Gómara MJ; García ML; Haro I
Int J Nanomedicine; 2015; 10():609-31. PubMed ID: 25670897
[TBL] [Abstract][Full Text] [Related]
17. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
[TBL] [Abstract][Full Text] [Related]
18. Intracellular Targeting of Poly Lactic-Co-Glycolic Acid Nanoparticles by Surface Functionalization with Peptides.
de Oliveira TD; Travassos LR; Arruda DC; Tada DB
J Biomed Nanotechnol; 2021 Jul; 17(7):1320-1329. PubMed ID: 34446135
[TBL] [Abstract][Full Text] [Related]
19. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
20. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
